MIR4513: A Drug Target / Disease Biomarker (G100616183)

MIR4513: A Drug Target / Disease Biomarker

MIR4513 is a protein that is expressed in various tissues of the body, including the lungs, heart, kidneys, and intestines. It is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells.

One of the unique features of MIR4513 is its ability to interact with multiple intracellular signaling pathways. This protein has been shown to play a role in a variety of biological processes, including cell signaling, DNA replication, and cell division.

MIR4513 has also been shown to have potential as a drug target. Studies have shown that MIR4513 can be targeted by small molecules, which could make it an attractive target for drug development. In addition, MIR4513 has been shown to interact with a variety of drugs, including those that are used to treat a variety of diseases, such as cancer and cardiovascular disease.

One of the potential benefits of targeting MIR4513 is its ability to regulate cell signaling pathways that are involved in the development and progression of many diseases. For example, MIR4513 has been shown to play a role in the development of cancer, and studies have shown that inhibiting its activity can lead to the regression of cancer tumors.

In addition, MIR4513 has also been shown to be involved in the regulation of cell division, which is a critical process that is involved in the growth and development of all cells. MIR4513 has been shown to play a role in the regulation of cell division, and studies have shown that alterations in its activity can lead to changes in cell division that can contribute to the development of cancer.

Another potential benefit of targeting MIR4513 is its ability to interact with a variety of signaling pathways. This protein has been shown to play a role in the regulation of multiple intracellular signaling pathways, including the TGF-β pathway, the PI3K/Akt pathway, and the NF-kappa-B pathway.

In addition, MIR4513 has also been shown to play a role in the regulation of DNA replication, which is a critical process that is involved in the growth and development of all cells. MIR4513 has been shown to play a role in the regulation of DNA replication, and studies have shown that alterations in its activity can lead to changes in DNA replication that can contribute to the development of cancer.

MIR4513 is also involved in the regulation of cell adhesion, which is a critical process that is involved in the formation and maintenance of tissues and organs. MIR4513 has been shown to play a role in the regulation of cell adhesion, and studies have shown that alterations in its activity can affect the formation and function of tissues and organs.

In conclusion, MIR4513 is a protein that is involved in a variety of biological processes that are important for the growth and development of all cells. Its ability to interact with multiple intracellular signaling pathways makes it an attractive target for drug development, and its potential as a drug target for the regulation of cancer and cardiovascular disease makes it a promising target for future research. Further studies are needed to fully understand the role of MIR4513 in these biological processes and its potential as a drug target.

Protein Name: MicroRNA 4513

The "MIR4513 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4513 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635 | MIR4638 | MIR4639 | MIR4640 | MIR4641 | MIR4642 | MIR4644 | MIR4645 | MIR4646 | MIR4647 | MIR4648 | MIR4649 | MIR4650-1 | MIR4650-2 | MIR4651 | MIR4652 | MIR4653 | MIR4655 | MIR4656 | MIR4657 | MIR4658 | MIR4659A | MIR4659B | MIR466 | MIR4660 | MIR4661 | MIR4662A | MIR4663 | MIR4664 | MIR4665 | MIR4666A | MIR4666B | MIR4667 | MIR4668 | MIR4669 | MIR4670 | MIR4671 | MIR4672 | MIR4673 | MIR4674 | MIR4675 | MIR4676 | MIR4677 | MIR4679-1 | MIR4679-2 | MIR4680 | MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706